VTVT vs. RNAC, TSVT, ALMS, INZY, GLUE, TERN, PVLA, LFCR, TNGX, and GOSS
Should you be buying vTv Therapeutics stock or one of its competitors? The main competitors of vTv Therapeutics include Cartesian Therapeutics (RNAC), 2seventy bio (TSVT), Alumis (ALMS), Inozyme Pharma (INZY), Monte Rosa Therapeutics (GLUE), Terns Pharmaceuticals (TERN), Palvella Therapeutics (PVLA), Lifecore Biomedical (LFCR), Tango Therapeutics (TNGX), and Gossamer Bio (GOSS). These companies are all part of the "pharmaceutical products" industry.
vTv Therapeutics vs.
Cartesian Therapeutics (NASDAQ:RNAC) and vTv Therapeutics (NASDAQ:VTVT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, community ranking, earnings, profitability, valuation, dividends and institutional ownership.
In the previous week, Cartesian Therapeutics had 5 more articles in the media than vTv Therapeutics. MarketBeat recorded 11 mentions for Cartesian Therapeutics and 6 mentions for vTv Therapeutics. Cartesian Therapeutics' average media sentiment score of 0.38 beat vTv Therapeutics' score of -0.14 indicating that Cartesian Therapeutics is being referred to more favorably in the media.
vTv Therapeutics received 314 more outperform votes than Cartesian Therapeutics when rated by MarketBeat users. However, 95.12% of users gave Cartesian Therapeutics an outperform vote while only 57.12% of users gave vTv Therapeutics an outperform vote.
vTv Therapeutics has lower revenue, but higher earnings than Cartesian Therapeutics. vTv Therapeutics is trading at a lower price-to-earnings ratio than Cartesian Therapeutics, indicating that it is currently the more affordable of the two stocks.
Cartesian Therapeutics has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500. Comparatively, vTv Therapeutics has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500.
vTv Therapeutics has a net margin of 0.00% compared to Cartesian Therapeutics' net margin of -510.72%. Cartesian Therapeutics' return on equity of 0.00% beat vTv Therapeutics' return on equity.
Cartesian Therapeutics currently has a consensus target price of $42.50, suggesting a potential upside of 357.97%. vTv Therapeutics has a consensus target price of $35.50, suggesting a potential upside of 83.50%. Given Cartesian Therapeutics' higher possible upside, research analysts plainly believe Cartesian Therapeutics is more favorable than vTv Therapeutics.
86.9% of Cartesian Therapeutics shares are held by institutional investors. Comparatively, 17.5% of vTv Therapeutics shares are held by institutional investors. 57.9% of Cartesian Therapeutics shares are held by company insiders. Comparatively, 4.2% of vTv Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Cartesian Therapeutics beats vTv Therapeutics on 11 of the 18 factors compared between the two stocks.
Get vTv Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
vTv Therapeutics Competitors List
Related Companies and Tools
This page (NASDAQ:VTVT) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy VTVT Stock Free VTVT Stock Alerts